AQUILON PHARMACEUTICALS
People
13
Locations
4
Publications
13
Company Profile
Founded Date
October 16, 2013
Last Balance Sheet Year
2024
Juridical Form
Naamloze vennootschap
Enterprise Type
Rechtspersoon
Activity
72101 - Speur- en ontwikkelingswerk op biotechnologisch gebied
Company Age
13 years
Contact Details
Unlock direct contact points, registry address detail, and website links for AQUILON PHARMACEUTICALS.
Unlock Contact Details
Reveal email, phone, website, and full registry contact information.
Create Free AccountHistorical Financials
| KPI | 2024 | 2023 | 2022 |
|---|---|---|---|
| Turnover | - | - | - |
| Gross Margin | €991,768 (+8.1%) | €917,235 (+103.3%) | €451,097 (+190.4%) |
| Profit | -€913,660 (+2.5%) | -€936,675 (-22.8%) | -€762,477 (-21.2%) |
| EBITDA | -€470,572 (+5.7%) | -€498,758 (-5.5%) | -€472,735 (+15.7%) |
| Equity | €1,296,242 (-30.4%) | €1,863,008 (+144.9%) | €760,758 (-50.1%) |
| Debt | €8,976,765 (+13.6%) | €7,905,296 (+12.1%) | €7,053,414 (+47.7%) |
| Total Assets | €10,306,004 (+5.3%) | €9,784,947 (+25.2%) | €7,815,276 (+24.1%) |
| Cash | €208,427 (-61.1%) | €535,282 (-11.3%) | €603,141 (-41.2%) |
| FTE | 9.4 (+2.2%) | 9.2 (+12.2%) | 8.2 (+17.1%) |
Unlock Full History
Create a free account to access up to 10 years of historical financial data for AQUILON PHARMACEUTICALS.
Create Free AccountFinancial Health
Ratio-level insight derived from the latest company and balance sheet data.
Current Ratio
0.1x
(-56.0%)
Quick Ratio
0.1x
(-56.0%)
Solvency
12.6%
(-33.9%)
Debt / Equity
6.9x
Unlock Advanced Metrics
Access the full ratio deck, benchmarking signals, and deeper profitability diagnostics.
Create Free AccountLocations & Footprint
Establishment
AddressNo data available
Establishment
AddressNo data available
Establishment
AddressNo data available
Unlock Full Footprint
See every known establishment, linked address, and operating footprint tied to AQUILON PHARMACEUTICALS.
Create Free AccountEntity Network
First-level relations linked directly to AQUILON PHARMACEUTICALS. Unlock second-level relations for deeper graph exploration.
AQUILON PHARMACEUTICALS
Active
- MAES PHARMCONSULT
Incoming link
Administrator Legal - SAMBRINVEST SPIN-OFF/SPIN-OUT
Incoming link
Administrator Legal - SCALE I
Incoming link
Administrator Legal -
Didier CATALDO
Incoming link
Administrator Natural -
Franck PIETERS
Incoming link
Administrator Natural -
Frank PIETERS
Incoming link
Administrator Natural -
Hassan BENAMEUR
Incoming link
Administrator Natural -
Joseph GHELDERE
Incoming link
Administrator Natural -
Michaël MELLINK
Incoming link
Administrator Natural -
Moshe MANOR
Incoming link
Administrator Natural - P&L Projects
Outgoing link
Participating Interest - SAMBRINVEST SPIN-OFF/SPIN-OUT
Outgoing link
Participating Interest - SCALE I
Outgoing link
Participating Interest -
Elisabeth DE HALLEUX
Incoming link
Administrator Legal Representative -
Gauthier VAN DER ELST
Incoming link
Administrator Legal Representative -
Gauthier VAN DER ELST Gauthier
Incoming link
Administrator Legal Representative -
Micheline Streel
Incoming link
Administrator Legal Representative -
Paul MAES
Incoming link
Administrator Legal Representative -
Thomas Donck
Incoming link
Administrator Legal Representative
Unlock Second-Level Relations
Expand beyond direct links to see second-level entities, people, and cross-company paths.
Free Sign UpManagement & Key People
Unlock linked people, governance roles, and enriched demographic signals associated with AQUILON PHARMACEUTICALS.
Management Profiles
Unlock directors, managers, role history, plus inferred gender and age where available.
Create Free Account